Alternatives to Juvenescence Uk Ltd

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Biotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Mapping cell-cell communication at scale in human tissue.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Drug discovery platform focused on developing therapeutics for age-related diseases.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company developing next-generation gene writing tools for advanced therapies.

Advance every cancer decision.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Biotechnology company developing novel immunotherapies for cancer.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Developing novel therapeutics for age-related diseases using senolytic compounds.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Phagos is developing bacteriophage therapies to combat antibiotic-resistant bacterial infections.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Develops senolytic drugs to clear senescent cells and promote cellular rejuvenation.

Developing transformative fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia.

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI-powered platform for antibody discovery and development to create new medicines.